Notice of Special Interest (NOSI): Epidemiologic Studies to Assess the Impact of Incretin Mimetics on New and Recurrent Cancer Risk
Notice NOT-CA-24-037 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 7, 2024 Category: Research Source Type: funding
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-23-280 from the NIH Guide for Grants and Contracts. The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk, and to draw talented scientists who understand the dynamic changes caused by these agents to investigate the mechanisms of how these agents influence cancer risk rather than shorter term outcomes such as weight loss and diabetes. The data thus far suggests that these agents may increa...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 24, 2023 Category: Research Source Type: funding
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
Funding Opportunity PAR-23-279 from the NIH Guide for Grants and Contracts. The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonists of GLP-1, GIP-1, or dual GLP-1/GIP-1 agents) impact cancer risk, and to draw talented scientists who understand the dynamic changes caused by these agents to investigate the mechanisms of how these agents influence cancer risk rather than shorter term outcomes such as weight loss and diabetes. The data thus far suggests that these agents may increa...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 23, 2023 Category: Research Source Type: funding
Reagents for Glucagon and Incretin Research (R43/R44)
Funding Opportunity Number: RFA-DK-14-008 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: Food and NutritionHealthCFDA Number: 93.847Eligible Applicants Small businessesAgency Name: HHS-NIH11Closing Date: Nov 24, 2014Award Ceiling: Expected Number of Awards: Creation Date: May 02, 2014Funding Opportunity Description: This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of:
A) Validat...
Source: Grants.gov - May 2, 2014 Category: Research Tags: Food and Nutrition Health Source Type: funding
Reagents for Glucagon and Incretin Research (R41/R42)
Funding Opportunity Number: PA-14-204 Opportunity Category: DiscretionaryFunding Instrument Type: GrantCategory of Funding Activity: Food and NutritionHealthCFDA Number: 93.847Eligible Applicants Small businessesAgency Name: HHS-NIH11Closing Date: May 07, 2017Award Ceiling: Expected Number of Awards: Creation Date: May 02, 2014Funding Opportunity Description: This Funding Opportunity Announcement (FOA) invites Small Business Innovation Technology Transfer Research (STTR) grant applications from small business concerns (SBCs) in partnership with non-profit research institutions for f...
Source: Grants.gov - May 2, 2014 Category: Research Tags: Food and Nutrition Health Source Type: funding
Reagents for Glucagon and Incretin Research (R43/R44)
Funding Opportunity RFA-DK-14-008 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of: A) Validated, highly sensitive, and specific assays for plasma glucagon B) Reagents for manipulation of glucagon receptor activity in the pancreatic islet and other tissues C) Reagents to be used to improve our understanding of pancreatic alpha-cell biology particularly in response to glucagon and incretins D) Reagents and ass...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 2, 2014 Category: Research Source Type: funding
Reagents for Glucagon and Incretin Research (R41/R42)
Funding Opportunity PA-14-204 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites Small Business Innovation Technology Transfer Research (STTR) grant applications from small business concerns (SBCs) in partnership with non-profit research institutions for funding to perform research leading to the development of: A) Validated, highly sensitive, and specific assays for plasma glucagon B) Reagents for manipulation of glucagon receptor activity in the pancreatic islet and other tissues C) Reagents to be used to improve our understanding of pancreatic alpha-cell biology pa...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 2, 2014 Category: Research Source Type: funding
